Tools and Technology to Measure Patient Adherence in CAM Research (SBIR [R43/R44])

The summary for the Tools and Technology to Measure Patient Adherence in CAM Research (SBIR [R43/R44]) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Tools and Technology to Measure Patient Adherence in CAM Research (SBIR [R43/R44]): This funding opportunity announcement (FOA) solicits Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose development of innovative tools, technology, and devices needed for objective assessment of patient adherence to complementary and alternative medicine (CAM) intervention studies particularly those involving biologically active agents and mind-body strategies.-NCCAM plans to commit approximately $1.5 M in FY 06 to fund 6-8 applications on developing innovative tools, technology and instruments for the accurate assessment of adherence to the use of CAM practices, interventions, and products. -Awards issued under the FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. -This FOA will utilize the SBIR (R43/R44) grant mechanisms for Phase I and Fast-Track applications. -Eligible organizations: Only United States SBCs are eligible to submit SBIR applications. A SBC is one that, on the date of award for both Phase I and Phase II funding agreements, meets ALL of the criteria as described in Section III. -Eligible individuals: Any individual with the skills, knowledge, and resources necessary to carry out the proposed research is invited to work with his/her organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH programs. On an SBIR application, the Project Director/Principal Investigator (PD/PI) must have his/her primary employment (more than 50%) with the SBC at the time of award and for the duration of the project. -Applicant SBCs may submit more than one application, provided each application is scientifically distinct.
Federal Grant Title: Tools and Technology to Measure Patient Adherence in CAM Research (SBIR [R43/R44])
Federal Agency Name: National Institutes of Health
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-AT-06-002
Type of Funding: Grant
CFDA Numbers: 93.213
CFDA Descriptions: Research and Training in Complementary and Alternative Medicine
Current Application Deadline: No deadline provided
Original Application Deadline: Multiple Receipt Dates - See Link to Full Announce
Posted Date: Apr 05, 2006
Creation Date: Apr 11, 2006
Archive Date: Jul 06, 2006
Total Program Funding: $15,000,000
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Others (see text field entitled "Additional Information on Eligibility" for clarification) Small businesses
Additional Information on Eligibility
Only United States small business concerns (SBCs) are eligible to submit SBIR applications. A small business concern is one that, at the time of award for both Phase I and Phase II SBIR awards, meets all of the following criteria: Is independently owned and operated, is not dominant in the field of operation in which it is proposing, has a place of business in the United States and operates primarily within the United States or makes a significant contribution to the US economy, and is organized for profit. Is (a) at least 51% owned and controlled by one or more individuals who are citizens of, or permanent resident aliens in, the United States, or (b) for SBIR only, it must be a for-profit business concern that is at least 51% owned and controlled by another for-profit business concern that is at least 51% owned and controlled by one or more individuals who are citizens of, or permanent resident aliens in, the United States. Has, including its affiliates, an average number of employees for the preceding 12 months not exceeding 500, and meets the other regulatory requirements found in 13 C.F.R. Part 121. Business concerns are generally considered to be affiliates of one another when either directly or indirectly, (a) one concern controls or has the power to control the other; or (b) a third-party/parties controls or has the power to control both. Control can be exercised through common ownership, common management, and contractual relationships. The term
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
NIH OER Webmaster
[email protected]
[email protected] If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants
Botanical Dietary Supplements Translational Research Teams (RM1 Clinical Trial Required)
Limited Competition: Research Resource for Natural Product Nuclear Magnetic Resonance Data...
Leveraging Data at Scale to Understand Natural Product Impacts on Whole Person Health (R01...
Natural Product Multi-Site Clinical Trial Data Coordinating Center (Collaborative U24 Clin...
Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials o...
Probiotics for Pediatric Illnesses
Cam Practitioner Research Education Project Grant Partnership
Complementary and Alternative Medicine Career Transition Award (K22)
More Grants from the National Institutes of Health
HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allow...
Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allow...
Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optio...
AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com